Woodline Partners’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-115,021
Closed -$2.14M 916
2025
Q1
$2.14M Buy
+115,021
New +$1.72M 0.01% 654
2024
Q2
Sell
-18,700
Closed -$92.8K 554
2024
Q1
$92.8K Buy
+18,700
New +$120K ﹤0.01% 524
2023
Q3
Sell
-354,382
Closed -$2.04M 586
2023
Q2
$2.04M Buy
354,382
+271,580
+328% +$1.76M 0.02% 429
2023
Q1
$527K Buy
+82,802
New +$790K 0.01% 523
2021
Q2
Sell
-135,662
Closed -$2.98M 588
2021
Q1
$2.98M Buy
+135,662
New +$2.65M 0.07% 246

Other funds holding ALHC

Woodline Partners's ALHC Position: Q2 2025 in Review

Woodline Partners sold out of Alignment Healthcare (ALHC) in Q2 2025, closing a stake of 115,021 shares — an estimated $2.14M sold.

Woodline Partners first reported a position in ALHC in Q1 2021 and held it in 5 quarters. The position peaked at $2.98M in Q1 2021. 217 funds tracked by Wall St. Rank hold ALHC as of Q2 2025.

  • Woodline Partners reported no remaining Alignment Healthcare position as of Q2 2025 after selling out during the quarter.
  • Woodline Partners sold 115,021 Alignment Healthcare shares in Q2 2025, an estimated $2.14M.
  • Woodline Partners first reported a position in Alignment Healthcare in Q1 2021 and held it in 5 quarters.
  • Woodline Partners's Alignment Healthcare position peaked at $2.98M in Q1 2021.
  • 217 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2025.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.